These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27496805)

  • 21. Impairment of PPAR
    Chung KW; Lee EK; Lee MK; Oh GT; Yu BP; Chung HY
    J Am Soc Nephrol; 2018 Apr; 29(4):1223-1237. PubMed ID: 29440279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
    Zuo N; Zheng X; Liu H; Ma X
    Int J Clin Exp Pathol; 2015; 8(9):10653-61. PubMed ID: 26617775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knocking out peroxisome proliferator-activated receptor (PPAR) alpha inhibits radiation-induced apoptosis in the mouse kidney through activation of NF-kappaB and increased expression of IAPs.
    Zhao W; Iskandar S; Kooshki M; Sharpe JG; Payne V; Robbins ME
    Radiat Res; 2007 May; 167(5):581-91. PubMed ID: 17474796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Contribution of Peroxisome Proliferator-Activated Receptor Alpha to the Relationship Between Toxicokinetics and Toxicodynamics of Trichloroethylene.
    Yoo HS; Cichocki JA; Kim S; Venkatratnam A; Iwata Y; Kosyk O; Bodnar W; Sweet S; Knap A; Wade T; Campbell J; Clewell HJ; Melnyk SB; Chiu WA; Rusyn I
    Toxicol Sci; 2015 Oct; 147(2):339-49. PubMed ID: 26136231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of Peroxisome Proliferator-Activated Receptor α in Bitter Melon Seed Oil-Corrected Lipid Disorders and Conversion of α-Eleostearic Acid into Rumenic Acid in C57BL/6J Mice.
    Chang YY; Su HM; Chen SH; Hsieh WT; Chyuan JH; Chao PM
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.
    Li G; Brocker CN; Xie C; Yan T; Noguchi A; Krausz KW; Xiang R; Gonzalez FJ
    J Gastroenterol Hepatol; 2018 May; 33(5):1138-1145. PubMed ID: 29141109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemafibrate inhibited renal dysfunction and fibrosis in a mouse model of adenine-induced chronic kidney disease.
    Horinouchi Y; Murashima Y; Yamada Y; Yoshioka S; Fukushima K; Kure T; Sasaki N; Imanishi M; Fujino H; Tsuchiya K; Shinomiya K; Ikeda Y
    Life Sci; 2023 May; 321():121590. PubMed ID: 36940907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
    McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
    J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
    Clemenz M; Frost N; Schupp M; Caron S; Foryst-Ludwig A; Böhm C; Hartge M; Gust R; Staels B; Unger T; Kintscher U
    Diabetes; 2008 May; 57(5):1405-13. PubMed ID: 18184928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.
    Sue YM; Chou HC; Chang CC; Yang NJ; Chou Y; Juan SH
    PLoS One; 2014; 9(8):e104079. PubMed ID: 25090113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urotensin II exerts antiapoptotic effect on NRK-52E cells through prostacyclin-mediated peroxisome proliferator-activated receptor alpha and Akt activation.
    Hsu YH; Chen TH; Chen YC; Cheng CY; Sue YM; Chen JR; Chen CH
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):168-74. PubMed ID: 23933501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
    Kersten S; Stienstra R
    Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor alpha protects against glomerulonephritis induced by long-term exposure to the plasticizer di-(2-ethylhexyl)phthalate.
    Kamijo Y; Hora K; Nakajima T; Kono K; Takahashi K; Ito Y; Higuchi M; Kiyosawa K; Shigematsu H; Gonzalez FJ; Aoyama T
    J Am Soc Nephrol; 2007 Jan; 18(1):176-88. PubMed ID: 17135395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of PPARgamma in myocardial infarction.
    Fliegner D; Westermann D; Riad A; Schubert C; Becher E; Fielitz J; Tschöpe C; Regitz-Zagrosek V
    Eur J Heart Fail; 2008 Jan; 10(1):30-8. PubMed ID: 18162196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
    Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.